corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 13496

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

DMA Forecasts $10.6 Billion in 2008 Pharmaceutical Sales via Direct Marketing; New Report Focuses on Pharmaceutical Industry
PharmaLive 2008 Apr 10
http://www.pharmatimes.com/clinicalnews/article.aspx?id=13216&src=EWorldNews


Full text:

This year, pharmaceutical companies are forecast to generate $10.6 billion in sales through direct marketing, and that figure is expected to hit $15.2 billion in 2012. These are key findings in a new Direct Marketing Association (DMA) report entitled “Direct Marketing Facts and Figures in the Pharmaceutical Industry.”

DMA’s new 127-page report provides pharmaceutical direct marketers with a comprehensive overview of their sector. Each of its nine chapters – Pharmaceutical Overview; Catalogs; Commercial Email; Direct Mail; Insert Media; Internet Marketing; Print Media; Broadcast Media; and Telephone Marketing – is broken down into three subsets of data – direct marketing spending, sales, and employment – and then further examined by market and intent of offer.

The report also contains more than 70 charts that help readers benchmark their own direct marketing progress.

According to DMA Research Manager Michelle Tiletnick, “Initially, DMA was going to include the pharmaceutical industry as part of our healthcare report, which was published in February. However, upon review of the information, we realized that pharmaceutical and healthcare marketers were different enough that each merited its own report.”

“Readers of our pharmaceutical report will certainly find that the American pharmaceutical industry employs direct marketing extensively and successfully,” Tiletnick said. “This report will help pharmaceutical marketers benchmark their current direct marketing efforts against the entire industry as well as prepare themselves for the coming years.”

Other key findings from “Direct Marketing Facts and Figures in the Pharmaceutical Industry” include:

· In 2008, pharmaceutical direct marketers will spend more than $1 billion on direct marketing, reap revenues of $10.6 billion, and see an advertising ROI of $10.27 on each $1 spent.

· Between 2007 and 2012, direct marketing-driven sales are projected to compound 9.4 percent annually.

· The business-to-business category is responsible for nearly 65 percent of pharmaceutical direct mail advertising today.

· Commercial email spending is projected to increase 21.9 percent each year from 2007 to 2012.

· In 2012, Internet advertising expenditures will be nearly $173 million, up from an expected $93.6 million this year.

· Direct marketing-driven Web-driven sales this year will total nearly $1.9 billion and by 2012 they will double – reaching nearly $3.8 billion.

· Print marketing will generate more than $2 billion in sales this year.

· Between 2007 and 2012, direct mail spending is forecast to grow 7.1 percent each year.

· Insert media sales is expected to surpass $41 million in 2008.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963